Means Investment CO. Inc. raised its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 16.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,559 shares of the healthcare conglomerate’s stock after buying an additional 353 shares during the quarter. Means Investment CO. Inc.’s holdings in UnitedHealth Group were worth $633,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the business. Crewe Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. Pearl River Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $35,000. Canton Hathaway LLC bought a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $36,000. OLD Second National Bank of Aurora boosted its position in shares of UnitedHealth Group by 70.0% during the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 70 shares during the last quarter. Finally, Laurel Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $42,000. 86.15% of the stock is owned by institutional investors and hedge funds.
NYSE:UNH opened at $247.63 on Friday. The company has a market capitalization of $235.33 billion, a P/E ratio of 19.23, a PEG ratio of 1.34 and a beta of 0.74. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.60 by $0.13. The company had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.04 EPS. On average, equities analysts forecast that UnitedHealth Group Inc will post 14.71 EPS for the current fiscal year.
A number of analysts have recently issued reports on the company. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday. Citigroup upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and lifted their price target for the company from $247.00 to $280.00 in a research report on Friday, May 10th. UBS Group assumed coverage on UnitedHealth Group in a research report on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 price target for the company. ValuEngine downgraded UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Thursday, April 18th. Finally, Barclays dropped their price target on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research report on Wednesday, April 17th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $290.84.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $239.02, for a total value of $1,195,100.00. Following the completion of the sale, the director now owns 77,993 shares in the company, valued at approximately $18,641,886.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $229.75, for a total value of $2,297,500.00. Following the completion of the sale, the director now owns 187,663 shares of the company’s stock, valued at approximately $43,115,574.25. The disclosure for this sale can be found here. Insiders sold a total of 27,930 shares of company stock valued at $6,746,683 in the last 90 days. 0.87% of the stock is currently owned by corporate insiders.
WARNING: “UnitedHealth Group Inc (UNH) Holdings Lifted by Means Investment CO. Inc.” was published by Enterprise Leader and is owned by of Enterprise Leader. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://theenterpriseleader.com/2019/05/25/unitedhealth-group-inc-unh-holdings-lifted-by-means-investment-co-inc.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: What is a Derivative?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.